130 related articles for article (PubMed ID: 1444302)
1. Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots.
Turcotte A; Bergeron MG
Antimicrob Agents Chemother; 1992 Oct; 36(10):2211-5. PubMed ID: 1444302
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Rybak MJ; Houlihan HH; Mercier RC; Kaatz GW
Antimicrob Agents Chemother; 1997 Jun; 41(6):1359-63. PubMed ID: 9174199
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.
Kang SL; Rybak MJ
Antimicrob Agents Chemother; 1995 Jul; 39(7):1505-11. PubMed ID: 7492094
[TBL] [Abstract][Full Text] [Related]
4. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
5. Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.
Bergeron MG; Turcotte A
Antimicrob Agents Chemother; 1986 Dec; 30(6):913-6. PubMed ID: 3545070
[TBL] [Abstract][Full Text] [Related]
6. Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration.
Michiels MJ; Bergeron MG
Antimicrob Agents Chemother; 1996 Jan; 40(1):203-11. PubMed ID: 8787906
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Entenza JM; Drugeon H; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1995 Jul; 39(7):1419-24. PubMed ID: 7492078
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci.
von Eiff C; Peters G
Zentralbl Bakteriol; 1996 Apr; 283(4):497-501. PubMed ID: 8737948
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing.
Jamjian C; Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1997 Apr; 27(4):129-38. PubMed ID: 9154409
[TBL] [Abstract][Full Text] [Related]
10. RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci.
Archer GL; Auger P; Doern GV; Ferraro MJ; Fuchs PC; Jorgensen JH; Low DE; Murray PR; Reller LB; Stratton CW
Diagn Microbiol Infect Dis; 1993; 16(3):223-6. PubMed ID: 8477576
[TBL] [Abstract][Full Text] [Related]
11. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Kang SL; Rybak MJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
Pechère JC
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
[TBL] [Abstract][Full Text] [Related]
13. Post-antibiotic effects of RP 59500 with Staphylococcus aureus.
Nougayrede A; Berthaud N; Bouanchaud DH
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():101-6. PubMed ID: 1399941
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel insertion of the macrolides-lincosamides-streptogramin B resistance transposon Tn554 in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Tillotson LE; Jenssen WD; Moon-McDermott L; Dubin DT
Antimicrob Agents Chemother; 1989 Apr; 33(4):541-50. PubMed ID: 2543284
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1985 Jul; 28(1):160-2. PubMed ID: 3929677
[TBL] [Abstract][Full Text] [Related]
16. Post-antibiotic effect of the new streptogramin RP 59500.
Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):642-5. PubMed ID: 1396777
[TBL] [Abstract][Full Text] [Related]
17. In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.
Fantin B; Leclercq R; Ottaviani M; Vallois JM; Maziere B; Duval J; Pocidalo JJ; Carbon C
Antimicrob Agents Chemother; 1994 Mar; 38(3):432-7. PubMed ID: 8203835
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of early fecal carriage of Enterococcus faecalis and Staphylococcus spp and their antimicrobial resistant patterns among healthy neonates born in a hospital setting in central Saudi Arabia.
El-Kersh TA; Marie MA; Al-Sheikh YA; Al-Agamy MH; Al Bloushy AA
Saudi Med J; 2016 Mar; 37(3):280-7. PubMed ID: 26905350
[TBL] [Abstract][Full Text] [Related]
19. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
Chambers HF
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
[TBL] [Abstract][Full Text] [Related]
20. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C
Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
